Table: Stella Pharma - Q1 parent results

Stella Pharma

07/08/2024 06:00

Aug 7 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to  
                Jun 30, 2024        Jun 30, 2023      Mar 31, 2025 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            61 mln              61 mln           930 mln    
                 (+0.0 pct)          (+33.3 pct)      (+245.1 pct) 
  Operating     loss 166 mln        loss 163 mln      loss 252 mln 
  Recurring     loss 161 mln        loss 164 mln      loss 257 mln 
  Net           loss 161 mln        loss 165 mln      loss 260 mln 
  EPS           loss 5.12 yen       loss 5.44 yen    loss 8.33 yen 
  Ann Div                                NIL              NIL      
  -Q2 div                                NIL              NIL      
  -Q4 div                                NIL              NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T